Leffler, Daniel A.
Harvard Medical School,
United States
2025 Rank: 64066
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Gastroenterology & Hepatology
SubField 2:
General & Internal Medicine
Rank in SubField 1: 949 out of 108265 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 64066 | 66097 |
| Total Cites | 12340 | 14164 |
| H-index | 52 | 54 |
| Hm-index | 17 | 19 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 61 | 66 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 3269 | 3588 |
| Number of Single+First+Last Authored Papers | 96 | 96 |
| Total Cites to Single+First+Last Authored Papers | 4897 | 5408 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8414 | 9008 |
| Ratio of Total Citations to Distinct Citing Papers | 1.47 | 1.57 |
| Self-Citation Percentage |
12.88%
|
|
Leffler, Daniel A.
Harvard Medical School,
United States
2024 Rank: 67825
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Gastroenterology & Hepatology
SubField 2:
General & Internal Medicine
Rank in SubField 1: 1019 out of 103730 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 67825 | 69361 |
| Total Cites | 10774 | 12365 |
| H-index | 48 | 50 |
| Hm-index | 16 | 18 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 59 | 64 |
| Number of Single+First Authored Papers | 36 | 36 |
| Total Cites to Single+First Authored Papers | 2981 | 3283 |
| Number of Single+First+Last Authored Papers | 93 | 93 |
| Total Cites to Single+First+Last Authored Papers | 4413 | 4886 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7505 | 8053 |
| Ratio of Total Citations to Distinct Citing Papers | 1.44 | 1.54 |
| Self-Citation Percentage |
12.87%
|
|
Leffler, Daniel A.
Harvard Medical School,
United States
2023 Rank: 70401
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Gastroenterology & Hepatology
SubField 2:
General & Internal Medicine
Rank in SubField 1: 1064 out of 98720 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 70401 | 72334 |
| Total Cites | 9454 | 10946 |
| H-index | 45 | 46 |
| Hm-index | 16 | 17 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 59 | 64 |
| Number of Single+First Authored Papers | 35 | 35 |
| Total Cites to Single+First Authored Papers | 2702 | 2997 |
| Number of Single+First+Last Authored Papers | 92 | 92 |
| Total Cites to Single+First+Last Authored Papers | 3990 | 4449 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6617 | 7131 |
| Ratio of Total Citations to Distinct Citing Papers | 1.43 | 1.53 |
| Self-Citation Percentage |
13.63%
|
|
Leffler, Daniel A.
Harvard Medical School,
United States
2022 Rank: 74361
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Gastroenterology & Hepatology
SubField 2:
General & Internal Medicine
Rank in SubField 1: 1108 out of 95371 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 74361 | 76219 |
| Total Cites | 7785 | 9065 |
| H-index | 41 | 44 |
| Hm-index | 15 | 16 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 58 | 63 |
| Number of Single+First Authored Papers | 35 | 35 |
| Total Cites to Single+First Authored Papers | 2375 | 2647 |
| Number of Single+First+Last Authored Papers | 89 | 89 |
| Total Cites to Single+First+Last Authored Papers | 3444 | 3855 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5564 | 6025 |
| Ratio of Total Citations to Distinct Citing Papers | 1.40 | 1.50 |
| Self-Citation Percentage |
14.12%
|
|
Leffler, Daniel A.
Harvard Medical School,
United States
2021 Rank: 78373
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Gastroenterology & Hepatology
SubField 2:
General & Internal Medicine
Rank in SubField 1: 1138 out of 91513 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 78373 | 81731 |
| Total Cites | 7037 | 8237 |
| H-index | 40 | 41 |
| Hm-index | 14 | 15 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 54 | 59 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 2176 | 2440 |
| Number of Single+First+Last Authored Papers | 84 | 84 |
| Total Cites to Single+First+Last Authored Papers | 3157 | 3557 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 5099 | 5537 |
| Ratio of Total Citations to Distinct Citing Papers | 1.38 | 1.49 |
| Self-Citation Percentage |
14.57%
|
|
Leffler, Daniel A.
Takeda Pharmaceutical Company Limited,
United States
2020 Rank: 85660
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Gastroenterology & Hepatology
SubField 2:
General & Internal Medicine
Rank in SubField 1: 1263 out of 76367 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 85660 | 88033 |
| Total Cites | 5523 | 6588 |
| H-index | 36 | 37 |
| Hm-index | 13 | 14 |
| Number of Single Authored Papers | 4 | 4 |
| Total Cites to Single Authored Papers | 52 | 57 |
| Number of Single+First Authored Papers | 34 | 34 |
| Total Cites to Single+First Authored Papers | 1834 | 2078 |
| Number of Single+First+Last Authored Papers | 80 | 80 |
| Total Cites to Single+First+Last Authored Papers | 2637 | 3001 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4077 | 4468 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.47 |
| Self-Citation Percentage |
16.17%
|
|